Sandra De Barros

779 total citations
17 papers, 603 citations indexed

About

Sandra De Barros is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Sandra De Barros has authored 17 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Sandra De Barros's work include Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sandra De Barros is often cited by papers focused on Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sandra De Barros collaborates with scholars based in France, Germany and United States. Sandra De Barros's co-authors include Anne Bouloumié, Coralie Sengenès, Marie Maumus, Alexandra Miranville, Alexia Zakaroff‐Girard, Max Lafontan, Jean Galitzky, Virginie Bourlier, Keith N. Frayn and Fredrik Karpe and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and Stem Cells.

In The Last Decade

Sandra De Barros

17 papers receiving 589 citations

Peers

Countries citing papers authored by Sandra De Barros

Since Specialization

Citations

This map shows the geographic impact of Sandra De Barros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra De Barros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra De Barros more than expected).

Fields of papers citing papers by Sandra De Barros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra De Barros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra De Barros. The network helps show where Sandra De Barros may publish in the future.

Co-authorship network of co-authors of Sandra De Barros

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra De Barros. A scholar is included among the top collaborators of Sandra De Barros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra De Barros. Sandra De Barros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension 2025 ·Journal of Hypertension ·Loïc Ysebaert, Caroline Protin, Lucie Obéric, (unknown), Sandra De Barros, (unknown), Ben Allal, (unknown), Anne Quillet‐Mary, Fabien Despas	1
2	Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life? 2024 ·HemaSphere ·(unknown), (unknown), (unknown), Amélie Anota, Faustine Lhomme, Guillaume Manson, Sophie de Guibert, (unknown), (unknown), (unknown), Sandra De Barros, Loïc Ysebaert, (unknown), Mélanie Cogne, (unknown), Roch Houot, Aline Moignet	3
3	Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters 2022 ·Cancers ·Anne Gomez‐Brouchet, (unknown), Adeline Ledoux, (unknown), Sandra De Barros, (unknown), Fabien Despas, (unknown), (unknown), Corinne Bouvier, Sébastien Aubert, Gonzague de Pinieux, Fréderique Larousserie, Louise Galmiche, Franck Talmont, Stuart M. Pitson, Marie‐Lise Maddelein, Olivier Cuvillier	1
4	Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011 2022 ·Cancers ·(unknown), Sandra De Barros, Camille Laurent, Amandine Durand, Cyrille Delpierre, (unknown), (unknown), (unknown), Salim Kanoun, Jean Bastié, Olivier Casasnovas, Cédric Rossi	3
5	Population PK‐PD Modeling of Circulating Lymphocyte Dynamics in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment 2021 ·Clinical Pharmacology & Therapeutics ·(unknown), Loïc Ysebaert, Fabien Despas, Sandra De Barros, Lucie Obéric, Ben Allal, Étienne Chatelut, Mélanie White‐Koning	2
6	Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies 2020 ·Clinical Pharmacokinetics ·(unknown), Loïc Ysebaert, Fabien Despas, Sandra De Barros, Loı̈c Dupré, Anne Quillet‐Mary, Caroline Protin, Fabienne Thomas, Lucie Obéric, Ben Allal, Étienne Chatelut, Mélanie White‐Koning	15
7	Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population‐based study in France 2020 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), Aurore Palmaro, (unknown), Sandra De Barros, Françoise Huguet, Guy Laurent, Maryse Lapeyre‐Mestre, Fabien Despas	7
8	The impact of chronic myeloid leukemia on employment: the French prospective study 2018 ·Annals of Hematology ·Sandra De Barros, (unknown), Fabien Despas, (unknown), (unknown), (unknown), Éric Delabesse, Jean‐Marc Soulat, Guy Laurent, Françoise Huguet, Fabrice Hérin	7
9	Comparison between pediatric and adult adipose mesenchymal stromal cells 2016 ·Cytotherapy ·Olivier Abbo, Marion Taurand, Paul Monsarrat, Isabelle Raymond‐Letron, Emmanuelle Arnaud, Sandra De Barros, Françoise Auriol, Philippe Galinier, Louis Casteilla, Valérie Planat‐Benard	10
10	Aging-related Decrease of Human ASC Angiogenic Potential Is Reversed by Hypoxia Preconditioning Through ROS Production 2012 ·Molecular Therapy ·Sandra De Barros, (unknown), Emmanuelle Arnaud, Corinne Barreau, (unknown), (unknown), Anne Galinier, Louis Casteilla, Valérie Planat‐Benard	66
11	Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres 2011 ·Experimental Cell Research ·Cécile Dromard, Philippe Bourin, M. André, Sandra De Barros, Louis Casteilla, Valérie Planat‐Benard	36
12	Endothelial and Cardiac Regeneration from Adipose Tissues 2010 ·Methods in molecular biology ·Louis Casteilla, Valérie Planat‐Benard, (unknown), Sandra De Barros, Corinne Barreau, Mireille André	8
13	Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages 2008 ·Circulation ·Virginie Bourlier, Alexia Zakaroff‐Girard, Alexandra Miranville, Sandra De Barros, Marie Maumus, Coralie Sengenès, Jean Galitzky, Max Lafontan, Fredrik Karpe, Keith N. Frayn, Anne Bouloumié	278
14	Le tissu adipeux : un donneur de cellules souches ? 2007 ·Cahiers de Nutrition et de Diététique ·Anne Bouloumié, Sandra De Barros, Marie Maumus, Jean Galitzky, Coralie Sengenès	2
15	Chemotaxis and Differentiation of Human Adipose Tissue CD34+/CD31− Progenitor Cells: Role of Stromal Derived Factor-1 Released by Adipose Tissue Capillary Endothelial Cells 2007 ·Stem Cells ·Coralie Sengenès, Alexandra Miranville, Marie Maumus, Sandra De Barros, Rudi Busse, Anne Bouloumié	90
16	Inhibition of Human Preadipocyte Proteasomal Activity by HIV Protease Inhibitors or Specific Inhibitor Lactacystin Leads to a Defect in Adipogenesis, Which Involves Matrix Metalloproteinase-9 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Sandra De Barros, Alexia Zakaroff‐Girard, Max Lafontan, Jean Galitzky, Virginie Bourlier	30
17	Protease Inhibitor Treatments Reveal Specific Involvement of Matrix Metalloproteinase-9 in Human Adipocyte Differentiation 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Virginie Bourlier, Alexia Zakaroff‐Girard, Sandra De Barros, (unknown), (unknown), Max Lafontan, Anne Bouloumié, Jean Galitzky	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact